David T. Smith

6.8k total citations · 2 hit papers
9 papers, 5.6k citations indexed

About

David T. Smith is a scholar working on Organic Chemistry, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, David T. Smith has authored 9 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 3 papers in Pharmaceutical Science and 1 paper in Molecular Biology. Recurrent topics in David T. Smith's work include Catalytic C–H Functionalization Methods (4 papers), Oxidative Organic Chemistry Reactions (4 papers) and Fluorine in Organic Chemistry (3 papers). David T. Smith is often cited by papers focused on Catalytic C–H Functionalization Methods (4 papers), Oxidative Organic Chemistry Reactions (4 papers) and Fluorine in Organic Chemistry (3 papers). David T. Smith collaborates with scholars based in United States. David T. Smith's co-authors include Jón T. Njardarson, Edon Vitaku, Michael D. Delost, Pradipta Das, Richard A. Hardin, Craig A. Ogle, Stephen K. Cope, Steven H. Bertz, Andy A. Thomas and Vlad K. Kumirov and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

David T. Smith

8 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals

2014 5.0k citations Edon Vitaku, David T. Smith et al. Journal of Medicinal Chemistry profile →
From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles

2018 294 citations Michael D. Delost, David T. Smith et al. Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by David T. Smith

Since Specialization

Citations

This map shows the geographic impact of David T. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Smith more than expected).

Fields of papers citing papers by David T. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Smith. The network helps show where David T. Smith may publish in the future.

Co-authorship network of co-authors of David T. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Smith. A scholar is included among the top collaborators of David T. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Smith. David T. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Title	Journal	Authors	Indexed citations
1	Oxidative Route to Indoles via Intramolecular Amino-Hydroxylation of o-Allenyl Anilines	The Journal of Organic Chemistry	David T. Smith, Vlad K. Kumirov et al.	2
2	From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles breakdown →	Journal of Medicinal Chemistry	Michael D. Delost, David T. Smith et al.	294
3	A Survey of the Structures of US FDA Approved Combination Drugs	Journal of Medicinal Chemistry	Pradipta Das, Michael D. Delost et al.	241
4	Dearomatization Approach to 2-Trifluoromethylated Benzofuran and Dihydrobenzofuran Products	Organic Letters	David T. Smith, Edon Vitaku et al.	29
5	Metal‐Free Synthesis of Fluorinated Indoles Enabled by Oxidative Dearomatization	Angewandte Chemie	Edon Vitaku, David T. Smith et al.	10
6	Metal‐Free Synthesis of Fluorinated Indoles Enabled by Oxidative Dearomatization	Angewandte Chemie International Edition	Edon Vitaku, David T. Smith et al.	34
7	A Scalable Rhodium‐Catalyzed Intermolecular Aziridination Reaction	Angewandte Chemie International Edition	David T. Smith, Jón T. Njardarson	11
8	Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals breakdown →	Journal of Medicinal Chemistry	Edon Vitaku, David T. Smith et al.	4967
9	Complexes of the Gilman Reagent with Double Bonds across the π–σ Continuum	Organometallics	Steven H. Bertz, Stephen K. Cope et al.	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact